Bruce Linton On TerrAscend-Gage $545M Deal скачать в хорошем качестве

Bruce Linton On TerrAscend-Gage $545M Deal

Gage executive chairman and Creso Pharma (ASX: CPH) strategic advisor Bruce Linton joins The Dales Report once again to discuss the $545 million all-stock deal that saw TerrAscend purchase Gage Cannabis. Linton also discusses another topic that has perked the interest of cannabis investors worldwide, as he details the fallout between Creso Pharma and Red Light Holland. Here’s some highlights from the interview: Through the purchase, TerrAscend gains access to the third-largest cannabis market in the U.S in Michigan Linton goes into his thought process when making all stock transactions, highlighting some of the difficulties that often come about when trying to structure a deal of this magnitude Linton further explained that the partnership eliminates some of the largest growth concerns faced by each brand Creso Pharma and the possibility that the cannabis producer could be looking to expand its international footprint Linton reveals that Creso has recently developed a CBD product in Switzerland with the expectation that the product could be readily available in America Bruce explains last week’s announcement of the termination of an agreement between Creso and Red Light Holland About Channel: We are a business news platform that provides the latest and best insight on the stories making headlines around the world. We give Institutional and retail investors an inside edge in the competitive world of investing and profile companies that are making waves in their ever-growing industries. We are The Dales Report. Check out our website: https://thedalesreport.com/​​ Subscribe to our channel at https://article.thedalesreport.com/yo... Connect with us on our social media handles: Twitter:   / thedalesreport​​   Instagram:   / thedalesrep...​   Tiktok:   / thedalesrepor...​   Facebook:   / thedalesreport